Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J1KS
|
|||
| Former ID |
DNCL001651
|
|||
| Drug Name |
BMS-945429
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
Bristol-Myers Squibb; Alder Biopharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01545050) Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.